H.–R. Zerkowski

1.7k total citations
41 papers, 1.3k citations indexed

About

H.–R. Zerkowski is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, H.–R. Zerkowski has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 13 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in H.–R. Zerkowski's work include Receptor Mechanisms and Signaling (10 papers), Cardiac electrophysiology and arrhythmias (10 papers) and Cardiac Valve Diseases and Treatments (6 papers). H.–R. Zerkowski is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Cardiac electrophysiology and arrhythmias (10 papers) and Cardiac Valve Diseases and Treatments (6 papers). H.–R. Zerkowski collaborates with scholars based in Germany, Switzerland and United States. H.–R. Zerkowski's co-authors include Otto‐Erich Brodde, O.‐E. Brodde, N. Doetsch, Martin C. Michel, N.M. Deighton, Shigeru Motomura, J. J. Beckeringh, Hans Pargger, Jardena J. Puder and Beat P. Müller‐Stich and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Circulation Research.

In The Last Decade

H.–R. Zerkowski

40 papers receiving 1.2k citations

Peers

Countries citing papers authored by H.–R. Zerkowski

Since Specialization

Citations

This map shows the geographic impact of H.–R. Zerkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.–R. Zerkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.–R. Zerkowski more than expected).

Fields of papers citing papers by H.–R. Zerkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.–R. Zerkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.–R. Zerkowski. The network helps show where H.–R. Zerkowski may publish in the future.

Co-authorship network of co-authors of H.–R. Zerkowski

This figure shows the co-authorship network connecting the top 25 collaborators of H.–R. Zerkowski. A scholar is included among the top collaborators of H.–R. Zerkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.–R. Zerkowski. H.–R. Zerkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increased cardiac endothelial nitric oxide synthase expression in patients taking angiotensin‐converting enzyme inhibitor therapy 2006 ·European Journal of Clinical Investigation ·Henning Morawietz, Susanne Rohrbach, Uwe Rueckschloss, Eyk Schellenberger, K. Hakim, H.–R. Zerkowski, Georg Kojda, Dorothea Darmer, Juergen Holtz	11
2	Cortisol Response in Relation to the Severity of Stress and Illness 2005 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Jardena J. Puder, (unknown), Hans Pargger, H.–R. Zerkowski, Jürg Girard, Beat P. Müller‐Stich	183
3	Short- and Long-term Outcome after Lung Resection for Invasive Pulmonary Aspergillosis 2003 ·The Thoracic and Cardiovascular Surgeon ·Peter Matt, Franziska Bernet, James Habicht, Franco Gambazzi, Jakob Passweg, Aloïs Gratwohl, M. Tamm, H.–R. Zerkowski	11
4	Angiotensin-converting enzyme inhibitor therapy prevents upregulation of endothelin-converting enzyme-1 in failing human myocardium 2002 ·Biochemical and Biophysical Research Communications ·Henning Morawietz, Winfried Göettsch, Marten Szibor, Matthias Barton, S. Shaw, K. Hakim, H.–R. Zerkowski, Juergen Holtz	10
5	“Reverse remodeling” durch Chirurgie induzierbar? 2000 ·Zeitschrift für Kardiologie ·H.–R. Zerkowski, (unknown), (unknown), Henning Morawietz	1
6	Deloading of the Left Ventricle by Ventricular Assist Device Normalizes Increased Expression of Endothelin ETA Receptors But Not Endothelin-Converting Enzyme-1 in Patients With End-Stage Heart Failure 2000 ·Circulation ·Henning Morawietz, Marten Szibor, Winfried Göettsch, Babett Bartling, Matthias Barton, S. Shaw, Reiner Koerfer, H.–R. Zerkowski, Juergen Holtz	36
7	Improved outcome of APACHE II score-defined escalating systemic inflammatory response syndrome in patients post cardiac surgery in 1996 compared to 1988–1990: the ESSICS-study pilot project 2000 ·European Journal of Cardio-Thoracic Surgery ·Christian Kühn, Ursula Müller‐Werdan, D Schmitt, H. Lange, G. Pilz, E. Kreuzer, F. Mohr, H.–R. Zerkowski, Karl Werdan	18
8	Venous Microemboli in Patients with Artificial Heart Valves 1999 ·Cerebrovascular Diseases ·Dimitrios Georgiadis, Ralf W. Baumgartner, Frank Uhlmann, A. Lindner, H.–R. Zerkowski, S. Zierz	4
9	Altered Levels of mRNA of Apoptosis-Mediating Genes After Mid-Term Mechanical Ventricular Support in Dilative Cardiomyopathy - First Results of the Halle Assist Induced Recovery Study (HAIR) 1999 ·The Thoracic and Cardiovascular Surgeon ·Hendrik Milting, Babett Bartling, H. Schumann, Aly El‐Banayosy, (unknown), (unknown), Dorothea Darmer, Juergen Holtz, Reiner Körfer, H.–R. Zerkowski	33
10	Influence of transducer frequency on Doppler microemboli signals in an in vivo model 1998 ·Neurological Research ·Dimitrios Georgiadis, Andreas Wenzel, H.–R. Zerkowski, S. Zierz, A. Lindner	5
11	Further evidence of gaseous embolic material in patients with artificial heart valves 1998 ·Journal of Thoracic and Cardiovascular Surgery ·Dimitrios Georgiadis, Ralf W. Baumgartner, (unknown), A. Lindner, H.–R. Zerkowski	23
12	Transient outward current in human and rat ventricular myocytes 1993 ·Cardiovascular Research ·Erich Wettwer, Gregory Amos, (unknown), H.–R. Zerkowski, (unknown), Ursula Ravens	103
13	Bedeutung von β2-Adrenozeptoren bei Herzinsuffizienz 1992 ·Zeitschrift für Kardiologie ·O.‐E. Brodde, A Daul, M. C. Michel, H.–R. Zerkowski	4
14	Development of -adrenoceptor number and subtype distribution in the transplanted human heart 1991 ·European Heart Journal ·H.–R. Zerkowski, (unknown), O.‐E. Brodde	6
15	Chronic β₁‐adrenoceptor antagonist treatment sensitizes β₂‐adrenoceptors, but desensitizes M₂‐muscarinic receptors in the human right atrium 1990 ·British Journal of Pharmacology ·Shigeru Motomura, N.M. Deighton, H.–R. Zerkowski, N. Doetsch, Martin C. Michel, O.‐E. Brodde	72
16	Survival After Heart and Coronary-Artery Penetration by an Air-Rifle Projectile 1989 ·The Thoracic and Cardiovascular Surgeon ·N. Doetsch, U. Wolfhard, M.J. Mathers, H.–R. Zerkowski	7
17	Do human cardiac beta-2 adrenoceptors play a (patho)physiological role in regulation of heart rate and/or contractility? 1989 ·Basic Research in Cardiology ·Otto‐Erich Brodde, H.–R. Zerkowski	3
18	Drug- and disease-induced changes of human cardiac 1- and 2-adrenoceptors 1989 ·European Heart Journal ·Otto‐Erich Brodde, H.–R. Zerkowski, H. Borst, Willibald Maier, M. C. Michel	75
19	Selective regulation of β₁‐and β₂‐adrenoceptors in the human heart by chronic β‐adrenoceptor antagonist treatment 1988 ·British Journal of Pharmacology ·Martin C. Michel, (unknown), J. J. Beckeringh, H.–R. Zerkowski, N. Doetsch, O.‐E. Brodde	93
20	Beta-2 adrenoceptor-mediated relaxation of the isolated human saphenous vein. 1987 ·Journal of Pharmacology and Experimental Therapeutics ·Katsumi Ikezono, H.–R. Zerkowski, J. J. Beckeringh, M. C. Michel, O.‐E. Brodde	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact